Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound

investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2025

stock jumped early Thursday after the pharma giant reported adjusted earnings of $7.02 per share on $17.6 billion in third-quarter sales.
Analysts polled by FactSet expected Lilly to earn $5.89 a share on $16.05 billion in sales.
During the year-ago period, Lilly earned $1.18 per share…

This story appeared on investors.com, 2025-10-30 13:59:19.651000.
The Entire Business World on a Single Page. Free to Use →